These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 2199687

  • 1. [Tosufloxacin tosilate].
    Shimada K.
    Jpn J Antibiot; 1990 Apr; 43(4):583-602. PubMed ID: 2199687
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tosufloxacin tosilate-induced thrombocytopenic purpura.
    Takahama H, Tazaki H.
    J Dermatol; 2007 Jul; 34(7):465-7. PubMed ID: 17584324
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Emergence of resistance to fluoroquinolones among bacteria causing infections in food animals in Denmark.
    Aarestrup FM, Jensen NE, Jorsal SE, Nielsen TK.
    Vet Rec; 2000 Jan 15; 146(3):76-8. PubMed ID: 10674696
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro susceptibility of Nocardia spp. to a new fluoroquinolone, tosufloxacin (T-3262).
    Yazawa K, Mikami Y, Uno J.
    Antimicrob Agents Chemother; 1989 Dec 15; 33(12):2140-1. PubMed ID: 2619279
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Trovafloxacin: fourth generation fluoroquinolone.
    McNabb J, Nicolau D, Quintiliani R, Nightingale C.
    Conn Med; 1998 Aug 15; 62(8):483-7. PubMed ID: 9753805
    [No Abstract] [Full Text] [Related]

  • 14. Epidemiology of quinolone resistance: Europe and North and South America.
    Goldstein FW, Acar JF.
    Drugs; 1995 Aug 15; 49 Suppl 2():36-42. PubMed ID: 8549361
    [Abstract] [Full Text] [Related]

  • 15. [Studies of lomefloxacin in biliary tract infections].
    Ono Y, Kunii O.
    Jpn J Antibiot; 1989 Apr 15; 42(4):1017-24. PubMed ID: 2769934
    [Abstract] [Full Text] [Related]

  • 16. [Drug-induced pneumonitis with eosinophilic infiltration due to tosufloxacin tosilate].
    Kimura N, Miyazaki E, Matsuno O, Abe Y, Tsuda T.
    Nihon Kokyuki Gakkai Zasshi; 1998 Jul 15; 36(7):618-22. PubMed ID: 9805914
    [Abstract] [Full Text] [Related]

  • 17. Clinical assessment of tosufloxacin tosilate.
    Kohno S.
    J Infect Chemother; 2002 Mar 15; 8(1):19-27. PubMed ID: 11957115
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of tosufloxacin in the treatment of experimentally induced intra-abdominal infections in rats.
    Nord CE, Edlund C.
    Drugs Exp Clin Res; 1992 Mar 15; 18(3):89-92. PubMed ID: 1425208
    [Abstract] [Full Text] [Related]

  • 19. Major advances in antibacterial quinolone therapy.
    Neu HC.
    Adv Pharmacol; 1994 Mar 15; 29A():227-62. PubMed ID: 7826861
    [No Abstract] [Full Text] [Related]

  • 20. ESGAB breakpoint determination: temafloxacin.
    Phillips I, Acar J, Baquero F, Bergan T, Forsgren A, Wiedemann B.
    Eur J Clin Microbiol Infect Dis; 1991 Nov 15; 10(11):991-2. PubMed ID: 1665417
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.